Patent · US Expired

Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum

US4215993A · kind A · utility

14Cited by
5References
24Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 4, 1978
Grant dateAug 5, 1980
Priority date
Expiry dateDec 4, 1998

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/044
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A precipitating reagent and method is provided for isolating high density lipoproteins from low density lipoproteins in human serum together with a quantitative determination of high density lipoprotein cholesterol. Precipitation of low density lipoproteins is accomplished by the precipitating reagent without the addition of metal ions into the sample. The precipitating reagent lowers the pH of the human serum approximately to the isoelectric point of the low density lipoproteins through the use of an organic buffer. The precipitating reagent also contains a polyanion and neutral polymer. The preferred composition of the precipitating reagent contains about 0.4% phosphotungstic acid by weight thereof, about 2.5% of polyethylene glycol by weight thereof and 2-(N-morpholino) ethane sulfonic acid as the buffer present in a concentration of from about 0.2 molar to about 0.5 molar. According to the method provided, the precipitating reagent is added to the human serum sample thereby causing the low density lipoproteins to form a precipitate, leaving the high density lipoproteins in the resulting supernatant liquid. The supernatant is separated from the precipitate and a cholesterol assa…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.